Shu Wen Li

Director/Board Member at Impax Laboratories (Taiwan), Inc.

Health Technology

Profile

Shu Wen Li currently works for Impax Laboratories (Taiwan), Inc. as a Member-Supervisory Board member.
Currently, Mr. Li holds the position of Member-Supervisory Board at Impax Laboratories (Taiwan), Inc.

Shu Wen Li active positions

Companies	Position	Start
Impax Laboratories (Taiwan), Inc. Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan.	Director/Board Member	-

All active positions of Shu Wen Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shu Wen Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Impax Laboratories (Taiwan), Inc. Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan.	Health Technology